NVS
$124.13
Revenue | $14279.67Mn |
Net Profits | $4.02Mn |
Net Profit Margins | 0.03% |
Novartis Ag’s revenue jumped 14.13% since last year same period to $14279.67Mn in the Q2 2025. On a quarterly growth basis, Novartis Ag has generated 4.84% jump in its revenue since last 3-months.
Novartis Ag’s net profit fell -99.88% since last year same period to $4.02Mn in the Q2 2025. On a quarterly growth basis, Novartis Ag has generated -99.89% fall in its net profits since last 3-months.
Novartis Ag’s net profit margin fell -99.89% since last year same period to 0.03% in the Q2 2025. On a quarterly growth basis, Novartis Ag has generated -99.89% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.3 |
EPS Estimate Current Year | 2.3 |
Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 2.3 - a -2.95% fall from last quarter’s estimates.
Novartis Ag’s earning per share (EPS) estimates for the current year stand at 2.3.
Earning Per Share (EPS) | 2.42 |
Novartis Ag’s earning per share (EPS) jumped 22.84% since last year same period to 2.42 in the Q2 2025. This indicates that the Novartis Ag has generated 22.84% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-03-31 | 2.17 | 2.28 | 5.07% |
2025-07-17 | 2.37 | 2.42 | 2.11% |